What is the recommended dosage and treatment duration of Ativan (lorazepam) for a patient with anxiety and panic disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam Dosing for Anxiety and Panic Disorder

For anxiety disorders, initiate lorazepam at 2-3 mg/day divided into 2-3 doses (typically 0.5-1 mg per dose), with the largest dose at bedtime; for panic disorder specifically, mean effective doses are approximately 7 mg/day divided throughout the day. 1, 2

Standard Dosing Algorithm

Initial Dosing for Anxiety

  • Start with 2-3 mg/day in divided doses (e.g., 1 mg twice daily or 0.5-1 mg three times daily), with the largest dose before bedtime 1
  • The usual therapeutic range is 2-6 mg/day, though some patients may require 1-10 mg/day 1
  • For acute anxiety episodes, use 0.5-1 mg orally every 4-6 hours as needed, with a maximum of 4 mg/24 hours 3

Panic Disorder-Specific Dosing

  • Lorazepam demonstrates comparable efficacy to alprazolam for panic disorder at a mean daily dose of 7 mg/day 2
  • This is substantially higher than typical anxiety dosing and reflects the more severe nature of panic disorder 2
  • Both lorazepam and other benzodiazepines show rapid onset of antipanic effects that are maintained over 7-8 months without dose escalation 4

Dose Titration Strategy

  • Increase dosage gradually to minimize adverse effects 1
  • When higher doses are needed, increase the evening dose first before adjusting daytime doses 1
  • This approach capitalizes on the sedative effects during sleep while maintaining daytime function 1

Special Population Adjustments

Elderly or Debilitated Patients

  • Reduce initial dose to 1-2 mg/day in divided doses (e.g., 0.25-0.5 mg per dose) 1
  • Maximum dose should not exceed 2 mg/24 hours in elderly patients 5, 3
  • Elderly patients face significantly higher risks of falls, cognitive decline, and paradoxical agitation (occurring in approximately 10% of patients) 3, 6

Hepatic Impairment

  • For advanced liver disease, reduce initial dose to 0.25 mg orally 2-3 times daily 3

Treatment Duration and Discontinuation

Duration Considerations

  • Benzodiazepines should be reserved for short-term use or when psychological treatments are refused/unavailable 3
  • Regular use leads to tolerance, addiction risk, depression, and cognitive impairment 3
  • Efficacy is maintained for 7-8 months without dose escalation in panic disorder, though long-term use carries dependency risks 4

Discontinuation Protocol

  • Use gradual taper to reduce withdrawal risk 1
  • If withdrawal reactions develop, pause the taper or increase back to the previous dose level, then decrease more slowly 1
  • Discontinuation difficulties occur in a considerable number of panic disorder patients but can be minimized with proper tapering 4

Administration Details

Oral Concentrate Formulation

  • Mix with liquid (water, juice, soda) or semi-solid food (applesauce, pudding) using the calibrated dropper 1
  • Consume the entire mixture immediately; do not store for future use 1
  • Tablets can be used sublingually when swallowing is difficult 5, 3

Critical Safety Considerations

Contraindications

  • Severe pulmonary insufficiency, severe liver disease, and myasthenia gravis (except in moribund patients) 3
  • Do not combine with other sedatives due to significantly increased respiratory depression risk 3
  • Extreme caution required with concomitant high-dose olanzapine due to reported fatalities 3

Common Pitfalls to Avoid

  • Underdosing in panic disorder: The mean effective dose (7 mg/day) is substantially higher than typical anxiety dosing (2-3 mg/day) 2
  • Using as monotherapy for delirium-related agitation, which may worsen confusion 6
  • Abrupt discontinuation rather than gradual taper 1
  • Failing to reduce doses in elderly patients, leading to preventable adverse events 5, 3

Comparative Efficacy Evidence

Lorazepam demonstrates equivalent antipanic efficacy to alprazolam, with both drugs showing significant improvement throughout 6-week trials 2. The primary difference is dosing: lorazepam requires approximately 7 mg/day versus 3 mg/day for alprazolam to achieve comparable effects 2. Both medications are well-tolerated aside from sedative effects, and clonazepam may offer advantages as a first-line agent due to its longer duration of action 4.

References

Guideline

Lorazepam Dosage and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Use of benzodiazepines in panic disorder.

The Journal of clinical psychiatry, 1997

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Anxiety and Agitation in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.